Ascendia Pharmaceuticals has officially unveiled its new brand identity as *Ascendia Pharmaceutical Solutions*, marking a significant milestone in the company’s 13-year journey of growth and innovation in the pharmaceutical industry.
Click here to read the official Press Release about our new brand identity.
With this rebrand, Ascendia not only reflects its expanded capabilities but also solidifies its position as a leading contract development and manufacturing organization (CDMO) dedicated to advancing drug development from pre-clinical through to commercialization.
The rebrand to *Ascendia Pharmaceutical Solutions* is the culmination of over a decade of scientific breakthroughs, dedicated service, and rapid expansion. What began as a small team of experts specializing in formulation services for poorly soluble drugs has evolved into a robust organization of more than 50 professionals, all committed to providing tailored, cutting-edge solutions for pharmaceutical and biopharma companies across the globe. As the company continues to grow, it became important to refresh its brand to more accurately reflect the diverse and comprehensive services it offers to clients at every stage of drug development.
According to Dr. Jim Huang, founder and CEO of Ascendia, "Our name change defines who we are as a company and what we do for our clients. It highlights not only our past successes but also the growth path we envision for the future. Ascendia Pharmaceutical Solutions is an expression of our commitment to Making the Impossible Possible for our clients."
Over the years, Ascendia has built a reputation for delivering innovative solutions, particularly in the areas of bioavailability enhancement and solubility. With proprietary nanotechnologies, such as AmorSol®, EmulSol®, LipidSol™, and NanoSol®, the company has helped biopharma clients develop formulations that overcome the complex challenges associated with poorly soluble drugs.
But Ascendia's capabilities extend far beyond formulation development. The company provides a full suite of drug development services, including pre-formulation studies, cGMP manufacturing, analytical testing, and ICH stability services for a variety of dosage forms. Whether it's new chemical entities (NCEs), biologics, complex dosage forms, or 505(b)(2) product development, Ascendia offers a comprehensive range of services to meet the diverse needs of its partners.
Indicative of its expansion, Ascendia now operates a state-of-the-art 60,000 square-foot facility at the New Jersey Bioscience Center in North Brunswick. The facility is equipped with Class 100 (ISO 5), Class 10,000 (ISO 7), and Class 100,000 (ISO 8) cleanrooms, as well as advanced manufacturing suites. These world-class facilities are equipped to support both sterile and non-sterile manufacturing needs, ensuring Ascendia can offer cGMP-compliant services at every stage of the drug development lifecycle.
At the heart of Ascendia’s success lies its customer-centric approach, which is encapsulated in its *BEST* philosophy: Brilliant technology, Excellent service, Superior quality, and Trust. This guiding principle has helped Ascendia build a strong track record of reliability, and it continues to serve as the foundation of its new brand. Ascendia’s commitment to quality and innovation ensures that the company remains the partner of choice for biopharma companies seeking to bring novel therapies to market.
“Our growth is built on the expertise of our scientific teams, the power of our proprietary nanotechnologies, and our unwavering commitment to excellence,” Dr. Huang added. "As Ascendia Pharmaceutical Solutions, we will continue to live by our BEST philosophy, Making the Impossible Possible for our clients and advancing the future of medicine."
The rebrand to *Ascendia Pharmaceutical Solutions* signals not just a new chapter for the company, but a renewed dedication to pushing the boundaries of what’s possible in drug development and manufacturing. With a broader service offering and state-of-the-art facilities, Ascendia is poised to meet the evolving needs of the pharmaceutical industry.
As the pharmaceutical landscape continues to change, Ascendia remains committed to partnering with biopharma companies to bring life-changing therapies to market. With its experienced team, innovative technologies, and commitment to excellence, Ascendia Pharmaceutical Solutions is ready to make a lasting impact in the field of drug development.
This rebrand marks an exciting new phase for Ascendia, and the company is poised for even greater success in the years to come. Stay tuned for further innovations and developments!
To learn more about how Ascendia Pharmaceutical Solutions can support your drug development and manufacturing needs, reach out below or contact us directly for a consultation.